ArticlesDiagnosing and treating CAP in immunocompetent adultsVines-Douglas, Greta MSHS, PA-CAuthor Information EARN CATEGORY I CME CREDIT by reading this article and the article beginning on page 48 and successfully completing the posttest on page 53. Successful completion is defined as a cumulative score of at least 70% correct. This material has been reviewed and is approved for 1 hour of clinical Category I (Preapproved) CME credit by the AAPA. The term of approval is for 1 year from the publication date of January 2008. LEARNING OBJECTIVES List the physical examination findings associated with community-acquired pneumonia (CAP) Identify patients requiring inpatient versus outpatient management Identify the most common pathogens associated with CAP Determine an appropriate plan to treat the most common pathogens in an outpatient Greta Vines-Douglas practices at Family Care Specialists, Montebello, California, and is an instructor at Western University of Health Sciences, Pomona, California. She has indicated no relationships to disclose relating to the content of this article. DRUGS MENTIONED Amoxicillin Amoxillin/clavulanate (Augmentin) Azithromycin (Zithromax) Carbamazepine Cefpodoxime (Vantin) Ceftriaxone (Rocephin) Cefuroxime (Ceftin, Zinacef) Clarithromycin (Biaxin) Doxycycline (Doryx, Monodox, Vibramycin) Erythromycin (ERYC, Ery-Tab, PCE) Phenytoin (Dilantin, Phenytek) Telithromycin (Ketek) Journal of the American Academy of PAs: January 2008 - Volume 21 - Issue 1 - p 26-30 Buy Abstract Patient presentation, likely etiology, and test results provide the clues PAs need to successfully diagnose and treat community-acquired pneumonia. © 2008 American Academy of Physician Assistants.